Related Experiment Video
Updated: Aug 27, 2026
Preparation of Pooled Human Platelet Lysate pHPL as an Efficient Supplement for Animal Serum-Free Human Stem Cell Cultures
Published on: October 30, 2009
Clotted Apheresis Hematopoietic Stem Cell Product
Lefan Zhuang1, Jennifer Woo2, Franchesca Francisco1
1Division of Transfusion Medicine, Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.
The majority of the time hematopoietic progenitor cells (HPC) are collected through leukapheresis, where anticoagulants are necessary to prevent clotting of the apheresis circuit and HPC product. Although clotting of the product is a possible rare complication surrounding the HPC cryopreservation process, there have been no reports of clotting of fresh HPC product after collection. We report a case of progressive clotting of a fresh matched unrelated donor HPC product. Upon initial receipt, thin thread-like white clots were seen in the bag. In an attempt to isolate the clot, the product was aseptically aliquoted into 50 mL syringes. Within the next 60 minutes the small clots coalesced into a pink cylindrical jelly-like blood clot surrounded by serum. In the future, an anticoagulant can be added into the product prior to isolation of the clot.
The majority of the time hematopoietic progenitor cells (HPC) are collected through leukapheresis, where anticoagulants are necessary to prevent clotting of the apheresis circuit and HPC product. Although clotting of the product is a possible rare complication surrounding the HPC cryopreservation process, there have been no reports of clotting of fresh HPC product after collection. We report a case of progressive clotting of a fresh matched unrelated donor HPC product. Upon initial receipt, thin thread-like white clots were seen in the bag. In an attempt to isolate the clot, the product was aseptically aliquoted into 50 mL syringes. Within the next 60 minutes the small clots coalesced into a pink cylindrical jelly-like blood clot surrounded by serum. In the future, an anticoagulant can be added into the product prior to isolation of the clot.
